Copy to clipboard 
Medin Technologies, manufacturer of sterilization cases and trays for orthopedic implants and instruments, appointed Jim Engler as Chief Financial Officer and Gregg Olson as Vice President of Sales and Marketing.
Throughout his nearly 30-year career in finance, accounting, auditing, financial planning and analysis roles, Mr. Engler focused on continuous improvement by aligning financial and business metrics to support business strategy and high growth. He has been a key leader in debt and equity financings involving several leading venture capital and private equity firms, helping raise over $2 billion in capital for his prior companies.
Mr. Olson has a track record of over 35 years of medical industry sales and marketing experience, and held key business development positions at Avail Medical Products, Flextronics, Vention Medical and Confluent Medical Technologies. His experience includes serving multiple life sciences market segments, ranging from Fortune 500 corporations to early-stage companies.
Previous additions to the Medin executive team include Anthony M. Snyder as Chief Operating Officer, bringing 16 years of experience focused on driving business results in regulated and non-regulated industries. He held various Operations Management and Continuous Improvement roles for RBC Bearings, Danaher, Circor, Swanson Industries and Harley-Davidson Motor Company. Also joining the team this year is Hans de Waal, a medical device industry veteran with over 10 years of design and manufacturing experience. As Medin’s Vice President of Engineering and Program Management, he is responsible for guiding customers of all sizes through the technical decisions required to optimize their products for specific end markets.
These leadership expansions cap a record year for the company, marked by the second consecutive year of 20% growth in its core business and the successful acquisition of Advantage Manufacturing Technologies (AMT) in 2019.
CEO Bill Donaldson told BONEZONE, “While the growth Medin has experienced in 2019 is just the beginning, it is the culmination of a process that began in 2018 when I first joined the company. Medin has a strong history of innovation, execution and service, but was both operationally and financially challenged at the time of its acquisition by Seven Point Equity Partners.
“We have applied lean manufacturing principles to streamline the company’s operations, bring the right leadership on board and invest in systems and technology that position Medin best for market opportunities.
“Results have been encouraging, but our job is far from over. Looking ahead, I see tremendous potential in our current offerings, including performance and providing enhanced intelligence to medical professionals. We plan to expand our existing customer base while exploring new avenues to improve patient outcomes.”
Last year, Mr. Donaldson spoke with BONEZONE to share his lessons learned while leading change.
Medin Technologies collaborates with medical OEMs around the world to provide sterilization cases that showcase the brand identities of its customers. Medin is owned by Seven Point Equity Partners, a private investment firm.
